Announcements
Home ⟩ Insights
Insights
story
2 min read • February 10, 2017
Earth Science Tech: Another Marijuana Stock That Looks ‘Insanely Overvalued’
5 min read • February 9, 2017
Recent Cannabis Industry Deals Reveal Interesting Trends: Canadian Market Maturing Faster Than U.S.
1 min read • February 7, 2017
Medical Marijuana Reports Alzheimer’s Patient Received Brazillian Gov’t Permission to be Treated with Medical Marijuana Unit’s RSHO
1 min read • February 7, 2017
Marijuana Industry Expert Alan Brochstein On GW Pharma’s Earnings Tells Benzinga :NDA filing for Epidiolex Seems To Have Been Pushed Back Slightly, Co. Now Saying “Mid 2017” Instead Of H1, “Mid” Could Mean A Bit Later Than June 30th
4 min read • February 5, 2017
Marijuana Penny Stocks: 2 More Cannabis Companies With Suspicious Insider Activity
3 min read • February 3, 2017
Investing In Marijuana Stocks 2017: Last Week Was The Best So Far
3 min read • February 2, 2017
Canopy Growth, The Largest Marijuana Business In The World, Debuted On Toronto Stock Exchange
6 min read • February 2, 2017
Marijuana Industry Deals In 2017: The Most Relevant Transactions In The Cannabis Space
6 min read • January 31, 2017
Marijuana Stocks Having A Great 2017: Expert Explains What’s Going On Sector By Sector, Week By Week
4 min read • January 30, 2017
The 420 Investor Looks Into 2 Marijuana Stocks That Seem Overvalued
3 min read • January 26, 2017
International Law Expert Talks Challenges Of Servicing The Marijuana Industry
4 min read • January 25, 2017
Marijuana Legalization Around The World: Who’s Next?
Latest Headlines
View All
3 min read • April 30, 2026
Medical Cannabis Operators Face New Federal Compliance Costs as Schedule III Shift Advances
2 min read • April 29, 2026
This Southern State Is Still an Untapped Cannabis Market As Lawmakers Revisit Medical Marijuana Policy
3 min read • April 29, 2026
Vext Science Cannabis Co. Boosts Cash Flow 256% YoY, Margins Grow in 2025 Ahead of Ohio Push
3 min read • April 29, 2026
New Lawsuit Claims CMS Medicare Cannabis Program Undermines FDA-Approved Drug Development
4 min read • April 28, 2026
Psychedelics Enter Public Markets, Optimi CEO Points to Supply Bottleneck
3 min read • April 28, 2026
This Cannabis Giant Plans Nevada Registration, Here’s What Shareholders And Investors Need To Know
2 min read • April 28, 2026
TerrAscend Extends Cash Flow Streak To 15 Quarters As Growth Returns, Shares Pop
4 min read • April 27, 2026
DEA Opens Medical Marijuana Dispensary Registration Portal April 29: What Operators Need To Know
4 min read • April 27, 2026
Federal Cannabis Policy Just Changed Forever, Here’s What Rescheduling Order Really Means And What To Expect
4 min read • April 27, 2026
EXCLUSIVE: Safe Harbor Launches First Cannabis‑Ready 401K Plan
min read • April 27, 2026
Ligand to Acquire XOMA Royalty, Further Accelerating Profit Growth and Strengthening Ligand’s Position as a Leading Biopharma Royalty Aggregator
min read • April 27, 2026
Intellia Therapeutics Initiates Rolling Submission of Biologics License Application to FDA for Lonvoguran Ziclumeran (lonvo-z) as a One-Time Treatment for Hereditary Angioedema
Browse By Channels
After-Hours Center
Analyst Color
Analyst Ratings
Asia
Asset Sales
Be Your Own Boss
Binary Options
Biotech
Bonds
Broad U.S. Equity ETFs
Buybacks
Cannabis
CNBC
Commodities
Contracts
Crowdsourcing
Cryptocurrency
Currency ETFs
Dividends
Downgrades
Earnings
Earnings Beats
Earnings Misses
Econ #s
Economics
Education
Emerging Market ETFs
Emerging Markets
Entertainment
Entrepreneurship
Equities
ESG
ETFs
Eurozone
Events
Exclusives
Fast Money
FDA
Federal Reserve
Financial Advisors
Financing
Fintech
Forex
Futures
Gaming
General
Global
Government
Guidance
Health Care
Hedge Funds
Hot
Initiation
Insider Trades
Insurance
Interview
Intraday Update
IPOs
Large Cap
Latin America
Legal
Long Ideas
M&A
Macro Economic Events
Macro Notification
Management
marijuana
Market Summary
Market-Moving Exclusives
Markets
Media
Mid Cap
Movers
Movers & Shakers
New ETFs
News
Offerings
Opinion
Options
Penny Stocks
Personal Finance
Politics
Pre-Market Outlook
Press Releases
Previews
Price Target
Psychedelics
Psychology
Real Estate
Regulations
REIT
Reiteration
Restaurants
Retail Sales
Reviews
Rumors
SEC
Sector ETFs
Short Ideas
Short Sellers
Signals
Small Business
Small Cap
Small Cap Analysis
Social Media
Specialty ETFs
Sports
Sports Betting
Startups
Stock Split
Success Stories
Taxes
Tech
Technicals
Top Stories
Topics
Trading Ideas
Travel
Upgrades
WIIM
Join the Cannabis Revolution
Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.